Last reviewed · How we verify
Single Bond Universal
Single Bond Universal's mechanism of action is not publicly available.
At a glance
| Generic name | Single Bond Universal |
|---|---|
| Sponsor | Dow University of Health Sciences |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Unfortunately, there is limited information available on the exact mechanism of action of Single Bond Universal.
Approved indications
Common side effects
Key clinical trials
- Comparison Between Egyptian MTA, Biodentine Versus Calcium Hydroxide as Indirect Pulp Capping Materials In Permanent Teeth (PHASE4)
- HEMA-free Universal Adhesives for Restoring Non-carious Cervical Lesions (NA)
- Clinical Performance of Bioactive Restorative Materials (NA)
- Does a Highly Filled Injectable Resin Composite Work Better Alone or in Combination With a Nanohybride Resin Composite? (NA)
- Clinical Performance of Injectable Composite Resins in Class I Cavities (NA)
- Comparison of Bulk-Fill Composite Resins in Class II Restorations (NA)
- Efficacy of Universal Bonding Agents as Desensitizers (NA)
- Esthetics of Dental Composite and Adhesive System (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Single Bond Universal CI brief — competitive landscape report
- Single Bond Universal updates RSS · CI watch RSS
- Dow University of Health Sciences portfolio CI